FierceBiotech ٢٧ مارس ٢٠٢٦ Novartis pens $2B deal for allergy biotech with potential Xolair successor
FierceBiotech ٢٧ مارس ٢٠٢٦ AstraZeneca delivers dream result as phase 3 COPD hits breathe life into class rocked by flops
FierceBiotech ٢٦ مارس ٢٠٢٦ Wave crashes after obesity trial tracks 1% dip in body weight over 6 months
FierceBiotech ٢٦ مارس ٢٠٢٦ Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
FierceBiotech ٢٦ مارس ٢٠٢٦ Innate ends work on NK cell engager in phase 1/2 trial as part of ongoing pipeline refocus
FierceBiotech ٢٦ مارس ٢٠٢٦ Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA
FierceBiotech ٢٥ مارس ٢٠٢٦ FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
FierceBiotech ٢٥ مارس ٢٠٢٦ Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
FierceBiotech ٢٥ مارس ٢٠٢٦ After ph. 2 readout, analysts herald 'best-in-class potential' for Maze kidney candidate as stock plummets
FierceBiotech ٢٥ مارس ٢٠٢٦ BrightGene's oral dual agonist sees up to 8% weight loss at 8 weeks in slice of early data
FierceBiotech ٢٥ مارس ٢٠٢٦ Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China